Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. "We often see patients with chronic low back pain who ...
(RTTNews) - Medical technology company Stryker Corp. (SYK) announced Tuesday that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. Food and Drug ...
Stryker said Monday that its OptaBlate basivertebral nerve ablation system received 510(k) clearance from the Food and Drug Administration. The medical technology company said its OptaBlate BVNA is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results